Ilex Medical Statistics

Total Valuation

Ilex Medical has a market cap or net worth of ILS 800.59 million. The enterprise value is 673.78 million.

Market Cap	800.59M
Enterprise Value	673.78M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Apr 7, 2024

Share Statistics

Ilex Medical has 11.28 million shares outstanding. The number of shares has decreased by -0.25% in one year.

Current Share Class	n/a
Shares Outstanding	11.28M
Shares Change (YoY)	-0.25%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	61.94%
Owned by Institutions (%)	17.65%
Float	2.98M

Valuation Ratios

The trailing PE ratio is 14.49.

PE Ratio	14.49
Forward PE	n/a
PS Ratio	0.81
PB Ratio	1.24
P/TBV Ratio	1.30
P/FCF Ratio	9.66
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.96, with an EV/FCF ratio of 8.13.

EV / Earnings	12.29
EV / Sales	0.69
EV / EBITDA	6.96
EV / EBIT	10.78
EV / FCF	8.13

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.08.

Current Ratio	2.38
Quick Ratio	1.58
Debt / Equity	0.08
Debt / EBITDA	0.52
Debt / FCF	0.65
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.81% and return on invested capital (ROIC) is 6.41%.

Return on Equity (ROE)	8.81%
Return on Assets (ROA)	4.41%
Return on Invested Capital (ROIC)	6.41%
Return on Capital Employed (ROCE)	9.64%
Revenue Per Employee	4.41M
Profits Per Employee	245,794
Employee Count	223
Asset Turnover	1.00
Inventory Turnover	4.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.01% in the last 52 weeks. The beta is -0.12, so Ilex Medical's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	+14.01%
50-Day Moving Average	7,415.86
200-Day Moving Average	6,861.35
Relative Strength Index (RSI)	39.38
Average Volume (20 Days)	5,198

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ilex Medical had revenue of ILS 982.96 million and earned 54.81 million in profits. Earnings per share was 4.90.

Revenue	982.96M
Gross Profit	229.88M
Operating Income	69.00M
Pretax Income	74.44M
Net Income	54.81M
EBITDA	103.32M
EBIT	69.00M
Earnings Per Share (EPS)	4.90

Full Income Statement

Balance Sheet

The company has 181.00 million in cash and 54.19 million in debt, giving a net cash position of 126.81 million or 11.24 per share.

Cash & Cash Equivalents	181.00M
Total Debt	54.19M
Net Cash	126.81M
Net Cash Per Share	11.24
Equity (Book Value)	641.83M
Book Value Per Share	57.46
Working Capital	402.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 113.88 million and capital expenditures -31.03 million, giving a free cash flow of 82.85 million.

Operating Cash Flow	113.88M
Capital Expenditures	-31.03M
Free Cash Flow	82.85M
FCF Per Share	7.34

Full Cash Flow Statement

Margins

Gross margin is 23.39%, with operating and profit margins of 7.02% and 5.58%.

Gross Margin	23.39%
Operating Margin	7.02%
Pretax Margin	7.57%
Profit Margin	5.58%
EBITDA Margin	10.51%
EBIT Margin	7.02%
FCF Margin	8.43%

Dividends & Yields

This stock pays an annual dividend of 1.36, which amounts to a dividend yield of 1.92%.

Dividend Per Share	1.36
Dividend Yield	1.92%
Dividend Growth (YoY)	-28.80%
Years of Dividend Growth	n/a
Payout Ratio	27.85%
Buyback Yield	0.25%
Shareholder Yield	2.17%
Earnings Yield	6.85%
FCF Yield	10.35%

Dividend Details

Stock Splits

The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.

Last Split Date	Aug 21, 2000
Split Type	Forward
Split Ratio	9

Scores

Ilex Medical has an Altman Z-Score of 3.63.

Altman Z-Score	3.63
Piotroski F-Score	n/a